Log in
menu
RESOURCES
Guides
API
FAQ
Recent Changes
Report Issue
ABOUT
About Wikirate
Community
Data
Impact
All Categories
--------------
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
search
arrow_back_ios
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
arrow_forward_ios
AcelRx Pharmaceuticals Inc
+
Answer
history
edit
build
2022
Assets
Research
lock_open
47.5M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Costs and Expenses
Research
lock_open
38.4M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Cost of Goods and Services Sold
Research
lock_open
2.59M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Income Tax Expense Benefit
Research
lock_open
13,000
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Liabilities
Research
lock_open
25.7M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Long-term Debt
Research
lock_open
5.76M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Operating Income (Loss)
Research
lock_open
-36.6M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Research and Development Expense
Research
lock_open
5.19M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Address
Research
lock_open
25821 INDUSTRIAL BOULEVARD, HAYWARD, 94545
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Comprehensive Income Net of Tax
Research
lock_open
-35.1M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Net Income Attributable to the company
Research
lock_open
-35.1M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Assets
Research
lock_open
77.9M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Costs and Expenses
Research
lock_open
38.8M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Cost of Goods and Services Sold
Research
lock_open
3.75M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Income Tax Expense Benefit
Research
lock_open
5,000
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Liabilities
Research
lock_open
114M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Long-term Debt
Research
lock_open
13.8M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Operating Income (Loss)
Research
lock_open
-36M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Research and Development Expense
Research
lock_open
4.1M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Standard Industrial Classification Code
Research
lock_open
Pharmaceutical Preparations
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
«
1
2
3
...
10
»
1 - 20 of 187